Pubblicazioni

Biomarkers for cognitive impairment in alpha-synucleinopathies: an overview of systematic reviews and meta-analyses  (2024)

Autori:
Mantovani, Elisa; Martini, Alice; Dinoto, Alessandro; Zucchella, Chiara; Ferrari, Sergio; Mariotto, Sara; Tinazzi, Michele; Tamburin, Stefano
Titolo:
Biomarkers for cognitive impairment in alpha-synucleinopathies: an overview of systematic reviews and meta-analyses
Anno:
2024
Tipologia prodotto:
Articolo in Rivista
Tipologia ANVUR:
Articolo su rivista
Lingua:
Inglese
Formato:
Elettronico
Referee:
Nome rivista:
NPJ PARKINSON'S DISEASE
ISSN Rivista:
2373-8057
N° Volume:
10
Numero o Fascicolo:
211
Intervallo pagine:
1-17
Parole chiave:
Diagnostic markers; Parkinson's disease; Prognostic markers
Breve descrizione dei contenuti:
Cognitive impairment (CI) is common in α-synucleinopathies, i.e., Parkinson's disease, Lewy bodies dementia, and multiple system atrophy. We summarize data from systematic reviews/meta-analyses on neuroimaging, neurophysiology, biofluid and genetic diagnostic/prognostic biomarkers of CI in α-synucleinopathies. Diagnostic biomarkers include atrophy/functional neuroimaging brain changes, abnormal cortical amyloid and tau deposition, and cerebrospinal fluid (CSF) Alzheimer's disease (AD) biomarkers, cortical rhythm slowing, reduced cortical cholinergic and glutamatergic and increased cortical GABAergic activity, delayed P300 latency, increased plasma homocysteine and cystatin C and decreased vitamin B12 and folate, increased CSF/serum albumin quotient, and serum neurofilament light chain. Prognostic biomarkers include brain regional atrophy, cortical rhythm slowing, CSF amyloid biomarkers, Val66Met polymorphism, and apolipoprotein-E ε2 and ε4 alleles. Some AD/amyloid/tau biomarkers may diagnose/predict CI in α-synucleinopathies, but single, validated diagnostic/prognostic biomarkers lack. Future studies should include large consortia, biobanks, multi-omics approach, artificial intelligence, and machine learning to better reflect the complexity of CI in α-synucleinopathies.
Pagina Web:
https://doi.org/10.1038/s41531-024-00823-x
Id prodotto:
142358
Handle IRIS:
11562/1144606
ultima modifica:
11 dicembre 2024
Citazione bibliografica:
Mantovani, Elisa; Martini, Alice; Dinoto, Alessandro; Zucchella, Chiara; Ferrari, Sergio; Mariotto, Sara; Tinazzi, Michele; Tamburin, Stefano, Biomarkers for cognitive impairment in alpha-synucleinopathies: an overview of systematic reviews and meta-analyses «NPJ PARKINSON'S DISEASE» , vol. 10 , n. 2112024pp. 1-17

Consulta la scheda completa presente nel repository istituzionale della Ricerca di Ateneo IRIS

<<indietro

Attività

Strutture

Condividi